Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction
2023 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-023-38069-5
M
Marcel Benkhoff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
226
Citations
10
h-index
10
i10-index
Marcel Benkhoff is an academic researcher from University of Vienna. The author has contributed to research in topics: Antiplatelet Therapy and Cardiovascular Diseases & Sphingolipid Metabolism and Signaling & Acute Myocardial Infarction Research. The author has an h-index of 10, co-authored 28 publications.
ORCID: 0000-0001-6107-7421Papers by this author
worksLong-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration
2024 · Journal of Thrombosis and Haemostasis · 5 citations
https://doi.org/10.1016/j.jtha.2024.10.025
Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel
2024 · Basic Research in Cardiology · 3 citations
https://doi.org/10.1007/s00395-024-01073-x
METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation
2025 · ESC Heart Failure · 0 citations
https://doi.org/10.1002/ehf2.15330
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat